Ruxolitinib Suppresses Liver Fibrosis Progression and Accelerates Fibrosis Reversal via Selectively Targeting Janus Kinase 1/2
Zhenghui Song(TCM-Intigrated Cancer Center of Southern Medical University), Aimin Li(Washington University in St. Louis)
Cited by 1
Related Papers
Neonatal lethality in transgenic mice expressing prion protein with a deletion of residues 105–125
|The EMBO Journal|2007|213
N-Terminally Deleted Forms of the Prion Protein Activate Both Bax-Dependent and Bax-Independent Neurotoxic Pathways
|Journal of Neuroscience|2007|46
Wilms' tumour 1 can suppress hTERT gene expression and telomerase activity in clear cell renal cell carcinoma via multiple pathways
|British Journal of Cancer|2010|38
Ruxolitinib suppresses liver fibrosis progression and accelerates fibrosis reversal via selectively targeting Janus kinase 1/2
|Journal of Translational Medicine|2022|28